BHVN
BHVN
NYSE · Biotechnology

Biohaven Ltd

$9.63
+0.04 (+0.42%)
As of May 9, 1:33 AM ET ·
Day Range $9.52 — $9.89
52W Range $7.48 — $22.05
Open$9.70
Previous Close$9.59
Day High$9.89
Day Low$9.52
52W High$22.05
52W Low$7.48
Volume
Avg Volume1.82M
Market Cap1.47B
P/E Ratio
EPS$-6.96
SectorBiotechnology

Analyst Ratings

Strong Buy
25 analysts
19 Buy 6 Hold 0 Sell
Price Target +212.1% upside
Current
$9.63
Target
$30.06
$17.22 $30.06 avg $35.82

Key Financials

FY 2025 FY 2024 FY 2023
Revenue 166.56M 159.79M 165.80M
Net Income 26.40M 27.52M 28.79M
Profit Margin 15.9% 17.2% 17.4%
EBITDA 53.49M 47.96M 56.14M
Free Cash Flow 17.32M 22.87M 17.57M
Rev Growth +0.5% -2.4% +23.6%
Debt/Equity 0.62 0.47 0.55

Biotechnology Peers

Symbol Name Price Change P/E Mkt Cap
ABBV Abbvie Inc $201.55 -0.57% 88.1 372.29B
AMGN Amgen Inc $331.70 +0.79% 22.7 176.88B
GILD Gilead Sciences Inc $131.33 -2.04% 19.3 163.92B
VRTX Vertex Pharmaceuticals Inc $429.82 +1.13% 27.7 109.50B
REGN Regeneron Pharmaceuticals $714.89 +0.82% 16.5 74.30B
ALNY Alnylam Pharmaceuticals Inc $295.05 -0.29% 130.4 40.90B

Next Earnings

May 11, 2026
TBD
0 days away
EPS Est: $-0.84

BHVN News

No news for BHVN yet

Quick Stats

Market Cap1.47B
P/E Ratio
EPS$-6.96
Volume
SectorBiotechnology